SFTPD and chronic obstructive pulmonary disease: Whilst the precise pathogenic impact of decreased SP-D levels in BAL in such diseases has not so far been clearly elucidated, it is clear that low SP-D levels are a feature of COPD, becoming more significant with years of smoking [3].